| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,314 |
15,315 |
$1.02M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
3,100 |
2,712 |
$963K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,427 |
19,955 |
$866K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,857 |
2,133 |
$865K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,144 |
5,730 |
$402K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,706 |
5,377 |
$371K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,961 |
5,254 |
$348K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15,164 |
14,033 |
$203K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,773 |
7,854 |
$188K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,260 |
2,118 |
$162K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
8,200 |
7,662 |
$135K |
| 87632 |
|
657 |
448 |
$83K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
856 |
755 |
$78K |
| 92551 |
|
9,285 |
8,679 |
$71K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,790 |
3,920 |
$45K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
439 |
391 |
$36K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,753 |
3,407 |
$27K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,468 |
1,299 |
$27K |
| 90474 |
|
2,223 |
2,056 |
$18K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
700 |
442 |
$17K |
| 87581 |
|
652 |
447 |
$16K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
649 |
446 |
$16K |
| 87486 |
|
652 |
447 |
$16K |
| 99173 |
|
9,240 |
8,586 |
$15K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,424 |
3,799 |
$14K |
| 99381 |
|
145 |
135 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
3,434 |
3,161 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
216 |
186 |
$6K |
| 0072A |
|
157 |
133 |
$6K |
| 0071A |
|
168 |
123 |
$6K |
| 96161 |
|
655 |
538 |
$4K |
| 99383 |
|
41 |
41 |
$3K |
| 96127 |
|
1,837 |
1,492 |
$3K |
| 0002A |
|
78 |
72 |
$3K |
| 0001A |
|
75 |
69 |
$3K |
| 90677 |
|
707 |
569 |
$2K |
| 99382 |
|
24 |
24 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
69 |
42 |
$1K |
| 99215 |
Prolong outpt/office vis |
13 |
12 |
$1K |
| 81002 |
|
581 |
496 |
$1K |
| 90647 |
|
2,852 |
2,595 |
$1K |
| 87807 |
|
199 |
104 |
$1K |
| 99384 |
|
16 |
13 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
28 |
15 |
$769.95 |
| 96380 |
|
47 |
45 |
$673.17 |
| 99499 |
|
58 |
57 |
$646.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
62 |
52 |
$580.08 |
| 90656 |
|
570 |
455 |
$454.62 |
| 90651 |
|
621 |
582 |
$436.17 |
| 90620 |
|
40 |
36 |
$165.00 |
| 90670 |
|
3,603 |
3,151 |
$65.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
21 |
12 |
$28.50 |
| 90680 |
|
2,746 |
2,314 |
$25.00 |
| 90723 |
|
2,741 |
2,397 |
$25.00 |
| 90686 |
|
5,234 |
4,741 |
$12.50 |
| 94760 |
|
18 |
13 |
$6.57 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
81 |
39 |
$2.57 |
| 90633 |
|
1,494 |
1,339 |
$1.70 |
| 90381 |
|
44 |
35 |
$0.07 |
| 90707 |
|
1,310 |
1,203 |
$0.00 |
| 90700 |
|
354 |
319 |
$0.00 |
| 90734 |
|
429 |
400 |
$0.00 |
| 90715 |
|
102 |
87 |
$0.00 |
| 99072 |
|
200 |
89 |
$0.00 |
| 90713 |
|
12 |
12 |
$0.00 |
| 91300 |
|
208 |
170 |
$0.00 |
| 90716 |
|
1,305 |
1,200 |
$0.00 |
| 91307 |
|
386 |
301 |
$0.00 |
| 90696 |
|
213 |
200 |
$0.00 |
| 99000 |
|
90 |
72 |
$0.00 |